Founded in 2006 by Danish life science entrepreneurs Dr. Claus Christiansen and Dr. Bente Juel Riis, Sanos Group began with a commitment to scientific excellence in clinical research. Over the years, we have expanded our expertise through strategic acquisitions and the establishment of specialized units, evolving into a multi-niche Contract Research Organization (CRO) with a global presence.
Our full-service CRO journey includes the integration of NBCD, a leader in musculoskeletal research; NeuroScios, focusing exclusively on neurology and CNS disorders and Blueskin, dedicated to dermatology. This growth has enabled us to offer comprehensive clinical trial services across multiple therapeutic areas, supported by important in-house divisions such as the Sanos Clinics, the eCOA group, Patients Recruitment, Sanos Supply etc., making the Sanos offering a full-circle clinical experience.
Today, Sanos Group operates state-of-the-art research clinics, including a full-scale Phase 1 unit, and maintains a robust presence in Denmark, with expansions into Germany and the United States. Our dedication to scientific integrity, operational excellence, and patient-centricity drives us to accelerate drug development and improve patient outcomes with a global reach.